Global & Public Health (all articles)
Randomized Trial: Remdesivir Not Beneficial for Adults with Severe COVID-19
30 Apr, 2020 | 04:31h | UTCCommentaries: First randomized trial of remdesivir suggests antiviral drug is not associated with significant clinical benefits, more research needed – The Lancet AND Expert reaction to trial of remdesivir in adults – Science Media Centre
See also: [Not Published Yet] NIH Study Shows Remdesivir Accelerates Recovery from Advanced COVID-19
Related Commentary on Twitter
With all the hype about Remdesivir today @TheLancet has decided to lift the embargo and release this placebo-controlled multicenter study done in China that showed no benefit https://t.co/ZdmKfnWLyw
— Carlos del Rio (@CarlosdelRio7) April 29, 2020
Pooling of Samples for Testing for SARS-CoV-2 in Asymptomatic People
30 Apr, 2020 | 04:25h | UTCPooling of samples for testing for SARS-CoV-2 in asymptomatic people – The Lancet Infectious Diseases AND Commentary: Virologists show that sample pooling can massively increase coronavirus testing capacity – Saarland University
Related Preprint Study: Smart Pooled sample Testing for COVID-19: A Possible Solution for Sparsity of Test Kits – medRxiv AND Commentary: ‘Smart sample pooling’ for COVID-19 could solve test kit shortage problem – News Medical
[Not Published Yet] NIH Study Shows Remdesivir Accelerates Recovery from Advanced COVID-19
30 Apr, 2020 | 04:28h | UTCCommentaries: Hopes rise on coronavirus drug remdesivir – Nature AND The COVID-19 research news rollercoaster is running again: STAT News + Gilead’s remdesivir – HealthNews Review
See also: Randomized Trial: Remdesivir Not Beneficial for Adults with Severe COVID-19
Audio Interview: Loosening Covid-19 Restrictions
30 Apr, 2020 | 04:17h | UTCAudio Interview: Loosening Covid-19 Restrictions – New England Journal of Medicine
Men with COVID-19 Twice More Likely to Die than Women
30 Apr, 2020 | 04:21h | UTCNews Release: COVID-19 study shows that men have over double the death rate of women – Frontiers
Science Has an Ugly, Complicated Dark Side. And the Coronavirus Is Bringing It Out
30 Apr, 2020 | 04:10h | UTCScience Has an Ugly, Complicated Dark Side. And the Coronavirus Is Bringing It Out – Mother Jones
What Is the Infection-Fatality Rate of COVID-19?
30 Apr, 2020 | 04:04h | UTCWhat Is the Infection-Fatality Rate Of COVID-19? – Medium
USPSTF Statement: Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents
30 Apr, 2020 | 03:48h | UTCEditorial: Recommendations From the USPSTF for Prevention and Cessation of Tobacco Use in Children and Adolescents (free for a limited period)
Author Interview: USPSTF Recommendation: Tobacco Use Prevention and Cessation in Children and Adolescents
Commentary: USPSTF: Clinicians Should Counsel Kids to Not Start Smoking – NEJM Journal Watch
Perspective: Pandemic Science Out of Control
29 Apr, 2020 | 05:20h | UTCPandemic Science Out of Control – Issues in Science and Technology
Related Commentary on Twitter
"Especially in times of crisis, statistically meaningless, methodologically shoddy, and even fraudulent research can find a receptive audience in desperate patients, credulous doctors, and uninformed journalists." @JeanneLenzer1 & @ShannonBrownlee https://t.co/Jdw3nT3Z8E
— Issues in Science and Technology (@ISSUESinST) April 28, 2020
Perspective: What Policy Makers Need to Know About COVID-19 Protective Immunity
29 Apr, 2020 | 05:19h | UTCWhat policy makers need to know about COVID-19 protective immunity – The Lancet
Related: What Covid-19 antibody tests say — and don’t say — about immunity – Vox AND The False Hope of Antibody Tests – The Atlantic AND What Antibody Studies Can Tell You — and More Importantly, What They Can’t – ProPublica AND What if immunity to covid-19 doesn’t last? – MIT Technology Review AND Beware of Antibody-based COVID-19 “Immunity Passports” – Scientific American AND Coronavirus immunity: Can you catch it twice? – BBC
Related Commentary on Twitter
An especially astute and succinct essay on #COVID19 protective immunity @TheLancet todayhttps://t.co/HFGUGPdson
highlights unknowns on duration, role of T lymphocytes, what constitutes real protection, and herd immunity features pic.twitter.com/oBC48DcGCl— Eric Topol (@EricTopol) April 28, 2020
How Sweden Has Faced the Virus Without a Lockdown
29 Apr, 2020 | 04:53h | UTC‘Life Has to Go On’: How Sweden Has Faced the Virus Without a Lockdown – The New York Times
USPSTF Draft Statement: Not Enough Evidence to Recommend Hypertension Screening in Children
29 Apr, 2020 | 04:34h | UTCHigh Blood Pressure in Children and Adolescents: Screening – U.S. Preventive Services Task Force
Randomized Trial: Focal Mass Drug Administration and Reactive Focal Vector Control Can Reduce Malaria Transmission by 75%
29 Apr, 2020 | 04:32h | UTCCommentaries: Reducing malaria transmission with reactive focal interventions – The Lancet AND Smart interventions reduce malaria transmission by 75% – University of the Witwatersrand
IDSA Guidelines on Infection Prevention in Patients with Suspected or Known COVID-19
28 Apr, 2020 | 04:47h | UTC
Perspective: Pseudoscience and COVID-19 — We’ve Had Enough Already
28 Apr, 2020 | 04:35h | UTCPseudoscience and COVID-19 — we’ve had enough already – Nature
Aerodynamic Analysis of SARS-CoV-2 in Two Wuhan Hospitals
28 Apr, 2020 | 04:36h | UTCAerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals – Nature
Commentary: SARS-CoV-2 Found in Aerosols in Hospital Staff Areas, Public Places – NEJM Journal Watch AND Coronavirus Lingers in Air of Crowded Spaces, New Study Finds – Bloomberg AND Expert reaction to a Nature paper presenting evidence for the presence of SARS-CoV-2 RNA in the air – Science Media Centre
Which Epidemiologist do you Believe? The Debate About Lockdown is Not a Contest Between Good and Evil
28 Apr, 2020 | 04:33h | UTCWhich epidemiologist do you believe? – UnHeard
“The debate about lockdown is not a contest between good and evil”
Perspective: Scientists Who Express Different Views on Covid-19 Should Be Heard, not Demonized
28 Apr, 2020 | 04:30h | UTCScientists who express different views on Covid-19 should be heard, not demonized – STAT
Twitter-based Learning for Continuing Medical Education? A New Perspective for a Paradigm Shift in Medical Education, Accelerated by COVID-19
28 Apr, 2020 | 04:28h | UTCRelated: How Twitter is Changing Medical Research (texts on the subject)
Twentieth-Century Lessons for a Modern Coronavirus Pandemic
28 Apr, 2020 | 04:25h | UTCTwentieth-Century Lessons for a Modern Coronavirus Pandemic – JAMA
Related Podcasts: Pandemic Part 1: 1918 Flu Pandemic and COVID-19 – JAMA AND Pandemic Part 2: A Trip to Philadelphia’s Mutter Museum – JAMA
Study: Asymptomatic SARS-CoV-2 Infection Common Among Residents of a Large Homeless Shelter
28 Apr, 2020 | 04:26h | UTCPrevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston – JAMA
“36.0% had PCR test results positive for SARS-CoV-2… Among individuals with PCR test results positive for SARS-CoV-2, cough (7.5%), shortness of breath (1.4%), and fever (0.7%) were all uncommon, and 87.8% were asymptomatic”
Mitigating the Wider Health Effects of Covid-19 Pandemic Response
28 Apr, 2020 | 04:23h | UTCAnalysis: Mitigating the wider health effects of covid-19 pandemic response – The BMJ
Covid-19: What do We Know so Far About a Vaccine?
28 Apr, 2020 | 04:20h | UTCCovid-19: What do we know so far about a vaccine? – The BMJ
Pandemic Parlance: Public Health Needs new Language for the Coronavirus Pandemic
28 Apr, 2020 | 04:22h | UTCPandemic parlance: public health needs new language for the coronavirus pandemic – The BMJ Opinion
Global Injury Morbidity and Mortality from 1990 to 2017
28 Apr, 2020 | 04:14h | UTCRelated Studies: The Burden of Unintentional Drowning: Global, Regional and National Estimates of Mortality from the Global Burden of Disease Study AND Global and National Burden from Road Injuries